Apr 07, 2020
EmphyCorp N115 News: Reducing the Rate and Spread of COVID-19 with Nasal Nitric Oxide
Mar 17, 2020
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus
Mar 10, 2020
Dr. Ran Rubinstein Introduces ClariFix® for Relief from Chronic Rhinitis
Mar 10, 2020
SinuSonic Announces Publication of Study Results on First of its Kind Medical Device for Natural Relief of Nasal Congestion
Dec 12, 2019
GNO Snoring and Sinus Offers Compounded Nasal Sprays for Chronic Sinusitis
Jun 25, 2019
The global sinusitis drugs market size at a CAGR of over 6% during the forecast period
Feb 25, 2019
Glenmark Pharmaceuticals Announces Results from New Analysis of Pooled Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
Feb 19, 2019
Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
Jan 15, 2019
StellaPharma to Develop Epinephrine Nasal Spray Product
Aug 07, 2018
Glenmark Pharmaceuticals Announces FDA Acceptance of the Company's First New Drug Application for Ryaltris(TM) for Patients with Seasonal Allergic Rhinitis
May 24, 2018
Global Intranasal Drug Delivery Markets, 2016-2018 & 2024 - Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application
May 21, 2018
Glenmark Pharmaceuticals Announces the Company's First New Drug Application for Ryaltris(TM) for Patients with Seasonal Allergic Rhinitis
Mar 27, 2018
New survey reveals many misconceptions exist about allergies, illustrating the need for greater education
Mar 05, 2018
Glenmark Pharmaceuticals Presents New Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis at the AAAAI/WAO Joint Congress
Feb 26, 2018
Champion Baseball Pitcher Justin Verlander Teams Up with FLONASE® Allergy Relief for a Homerun Allergy Season
Feb 07, 2018
Impel NeuroPharma Announces Positive Results of Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache
Dec 13, 2017
Glenmark Pharmaceuticals Announces Top-Line Results from a Phase 3 Safety Study Evaluating Ryaltris(TM) in Patients with Perennial Allergic Rhinitis
Oct 31, 2017
Impel NeuroPharma Announces First Patient Dosed in Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache
Oct 23, 2017
Glenmark Pharmaceuticals Presenting New Data from Respiratory Portfolio at the ACAAI Annual Scientific Meeting 2017
Sep 14, 2017
Summit Biosciences Receives EU Approval for Commercial Manufacturing of Prescription Nasal Sprays